$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Increased in vitro production and serum levels of the soluble lipopolysaccharide receptor sCD14 in liver disease

Journal of hepatology : the journal of the European Association for the Study of the Liver, v.23 no.4, 1995년, pp.396 - 402  

Oesterreicher, C. (Universitatsklinik fur Innere Medizin IV, Klinische Abteilung Gastroenterologie und Hepatologie, ,, Vienna, Austria) ,  Pfeffel, F. ,  Petermann, D. ,  Muller, C.

Abstract AI-Helper 아이콘AI-Helper

Elevated concentrations of lipopolysaccharide have been found in serum of patients with severe parenchymal liver disease and its toxic effect is thought to be involved in hemodynamic disturbances seen in cirrhosis. A soluble form of the receptor (sCD14) for lipopolysaccharide is present in serum and...

참고문헌 (44)

  1. J Hepatol Fukui 12 162 1991 10.1016/0168-8278(91)90933-3 Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic disease; reevaluation with an improved chromogenic assay 

  2. Hepatology Lumsden 8 232 1988 10.1002/hep.1840080207 Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis 

  3. Digestion Gaeta 23 239 1982 10.1159/000198756 Endotoxinemia in a series of 104 patients with chronic liver disease: prevalence and significance 

  4. Gastroenterology Van Deventer 94 825 1988 10.1016/0016-5085(88)90261-2 Intestinal endotoxinemia: clinical significance 

  5. Prog Clin Biol Res Ulevitch 299 193 1989 Macrophages regulate the host response to bacterial lipopolysaccharides 

  6. Lancet Vallance 337 776 1991 10.1016/0140-6736(91)91384-7 Hyperdynamic circulation in cirrhosis: a role for nitric oxide? 

  7. Alcohol Clin Exp Res Honchel 16 665 1992 10.1111/j.1530-0277.1992.tb00656.x Tumor necrosis factor in alcohol enhanced endotoxin liver injury 

  8. Immunol Invest Nolan 18 325 1989 10.3109/08820138909112246 Intestinal endotoxins as co-factors in liver injury 

  9. Immunol Today Lynn 13 271 1992 10.1016/0167-5699(92)90009-V Lipopolysaccharides antagonists 

  10. Immunol Today Ziegler-Heitbrock 14 121 1993 10.1016/0167-5699(93)90212-4 CD14: cell surface receptor and differentiation marker 

  11. J Immunol Haziot 144 547 1988 10.4049/jimmunol.141.2.547 The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage 

  12. Science Wright 249 1431 1990 10.1126/science.1698311 CD14, receptor for lipopolysaccharides (LPS) and LPS-binding protein 

  13. Science Schumann 249 1429 1990 10.1126/science.2402637 Structure and function of lipopolysaccharide-binding protein 

  14. J Immuno Bazil 147 1567 1991 10.4049/jimmunol.147.5.1567 Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes 

  15. Eur J Immunol Bazil 16 1583 1986 10.1002/eji.1830161218 Biochemical characterization of a soluble form of the 53-kDa monocyte surface antigen 

  16. Res Immunol Schütt 143 71 1992 10.1016/0923-2494(92)80082-V Endotoxin-neutralizing capacity of soluble CD14 

  17. J Exp Med Frey 176 1665 1992 10.1084/jem.176.6.1665 Soluble CD14 participates in the response of cells to lipopolysaccharide 

  18. Clin Exp Immunol Horneff 91 207 1993 10.1111/j.1365-2249.1993.tb05884.x Reduction of monocyte-macrophage activation markers upon anti-CD4 treatment. Decreased levels of IL-1, IL-6, neopterin and soluble CD14 in patients with rheumatoid arthritis 

  19. J Immunol Haziot 151 1500 1993 10.4049/jimmunol.151.3.1500 Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide 

  20. Infection Immun Arditi 61 3149 1993 10.1128/IAI.61.8.3149-3156.1993 Endotoxin-mediated endothelial cell injury and activation: role of soluble CD14 

  21. Child 50 1984 Surgery and portal hypertension 

  22. J Hepatol Scheuer 13 372 1991 10.1016/0168-8278(91)90084-O Classification of chronic viral hepatitis: a need for reassessment 

  23. Clin Exp Immunol Krüger 85 297 1991 10.1111/j.1365-2249.1991.tb05722.x Serum CD14 levels in polytraumatized and severely burned patients 

  24. Immunobiology Krüger 181 244 1990 Elevated levels of soluble CD14 molecules in serum of HIV-1 infected patients 

  25. Frühjahrstagung für Immunologie Bartsch 13.2 1991 Erhöhte sCD14-Serumspiegel bei akut-exanthematischer Psoriasis 

  26. Arch Dermatol Res Wüthrich 284 339 1992 10.1007/BF00372036 Soluble CD14 but not interleukin-6 is a new market for clinical activity in atopic dermatitis 

  27. Scheuer 36 1980 

  28. Hepatology McClain 9 349 1989 10.1002/hep.1840090302 Increased tumor necrosis factor production by monocytes in alcoholic hepatitis 

  29. Transplantation Prickett 46 754 1988 10.1097/00007890-198811000-00024 Characterization of interstitial dendritic cells in human liver 

  30. Hepatology Keiser 7 1254 1987 10.1002/hep.1840070613 Hepatic extraction of renin: quantitation and characterization in the isolated perfused rat liver 

  31. J Cell Biol Gores 99 212A 1984 Hepatic handling of cholecystokinin peptides 

  32. J Hepatol Pfeffel 20 245 1994 10.1016/S0168-8278(05)80065-0 Soluble CD8 and soluble CD4 antigens in viral hepatitis and alcoholic cirrhosis 

  33. Clin Exp Immunol Deviere 77 221 1989 High interleukin-6 serum levels and increased production by leukocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production 

  34. Eur J Immunol Lauener 20 2375 1990 10.1002/eji.1830201103 Interleuken 4 down-regulates the expression of CD14 in normal human monocytes 

  35. J Leukoc Biol Landmann 52 323 1992 10.1002/jlb.52.3.323 Interferon-γ down-regulates soluble CD14 release in human monocytes and macrophages 

  36. Allerg Immunol Schütt 37 159 1991 sCD14 prevents endotoxin inducible oxidative burst response of human monocytes 

  37. Circ Shock Grunwald 39 220 1993 Endotoxin-neutralizing capacity of soluble CD14 is a highly conserved specific function 

  38. Proc Natl Acad Sci USA Pugin 90 2744 1993 10.1073/pnas.90.7.2744 Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14 

  39. J Cell Biol Dustin 107 321 1988 10.1083/jcb.107.1.321 Lymphocyte function associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanims for lymphocyte adhesion to cultured endothelial cells 

  40. J Clin Invest Colucci 71 1893 1983 10.1172/JCI110945 Cultured human endothelial cells generate tissue factor in response to endotoxin 

  41. J Clin Invest Moore 79 124 1987 10.1172/JCI112772 Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human endothelium in vitro 

  42. J Immunol Jirik 142 144 1989 10.4049/jimmunol.142.1.144 Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells 

  43. Adv Immunol Akira 54 1 1993 10.1016/S0065-2776(08)60532-5 Interleukin-6 in biology and medicine 

  44. Hepatology Shier 8 1151 1988 10.1002/hep.1840080532 ‘Peripheral arterial vasodilatation hypothesis’; a proposal for the initiation of renal sodium and water retention in cirrhosis 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로